Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verification of the neuroprotective efficacy of a selective receptor modulator in mouse and human models of the disease
2024/55/B/NZ7/02215
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ3_05: Neurobiologia molekularna
- NZ7_12: Prewencja chorób człowieka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Farmakologii PAN
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 6
Call
OPUS 28 – announced on 2024-09-16
- Amount awarded
- 1 994 212 PLN
- Project start date
- 2025-10-01
- Project end date
- 2028-09-30
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.